secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2025-04-03T23:59:59+00:00
Accession:  0001193125-25-071923
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical completes acquisition of Nevro Corp. for $5.85/share cash
------------------------------------------------------------------------

- Completed acquisition of Nevro on April 3, 2025; each Nevro share received $5.85 in cash.
- Nevro stock options and RSUs canceled; RSUs converted to cash equal to Merger Consideration.
- Acquisition expands Globus's addressable market opportunity to $2 billion in neuromodulation.
- Nevro common stock ceased trading on NYSE as of April 3, 2025.
- Globus plans to discuss merger benefits during Q1 2025 earnings call in May.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000119312525071923/0001193125-25-071923-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000119312525071923/d931031d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-071923

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer